PerkinElmer's Q1 Revenues Dip 1 Percent; Sequestration Hits Imaging Business | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its first-quarter revenues declined 1 percent as it missed the consensus Wall Street estimates on the top and bottom line.

The Waltham, Mass.-based firm brought in total revenues of $505.4 million for the three months ended March 31, down from $510.9 million in Q1 2012 and below the Wall Street estimate of $532.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.